Abstract
Little is known about exogenous inhibitors of low-density lipoprotein (LDL) aggregation. The search for nontoxic and bioavailable inhibitors of LDL aggregation is of interest, especially considering that the suppression of the aggregation of LDL might represent a therapeutic approach. We hypothesized that amphiphilic copolymers of propylene oxide and ethylene oxide, the so-called Pluronic block copolymers, can be used to influence the aggregation of LDL. In this work we used Pluronic® P85, L61 and F68. A comparative study of the effects of Pluronic block copolymers with various hydrophilic–lipophilic properties on the aggregation process of LDL showed that Pluronic copolymers with strong hydrophobic properties (P85 and L61) at concentrations close to or greater than the respective critical concentration of micelle formation inhibited the aggregation process of LDL; however, the “hydrophilic” Pluronic F68 had no effect on the aggregation of LDL at any concentration. Thus, the study demonstrated for the first time that Pluronic® block copolymers inhibit LDL self-association. The possibility of modulating the aggregation of LDL by various Pluronic copolymers can be regarded as a prerequisite in the creation of new types of anti-atherosclerotic drugs.
Similar content being viewed by others
Abbreviations
- ApoA:
-
Apolipoprotein
- ApoA-I:
-
High-density lipoprotein apolipoprotein
- BSA:
-
Bovine serum albumin
- HDL:
-
High-density lipoprotein(s)
- EO:
-
Ethylene oxide
- LDL:
-
Low-density lipoprotein(s)
- PO:
-
Propylene oxide
- VLDL:
-
Very low-density lipoprotein(s)
References
Anitschkow NN, Chatalov S (1913) Über experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehung einiger pathologischer Prozesse. Zentralbl Allg Pathol 24:1–9
Smith EB (1974) The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lpid Res 12:1–49
Mahley RW, Innerarity TL, Weisgraber KH, Oh SY (1979) Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective modification of lysine residues of apoproteins. J Clin Invest 64:743–750
Alaupovic P (1971) Apolipoproteins and lipoproteins. Atherosclerosis 13:141–146
Bobryshev YV (2006) Monocyte recruitment and foam cell formation in atherosclerosis. Micron 37:208–222
Bates SR, Wissler RW (1976) Effect of hyperlipemic serum on cholesterol accumulation in monkey aortic medial cells. Biochim Biophys Acta 450:78–88
Ross R, Harker L (1976) Hyperlipidemia and atherosclerosis. Science 193:1094–1100
Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333–337
Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA (1980) Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 77:2214–2218
Khoo JC, Miller E, McLoughlin P, Steinberg B (1990) Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. J Lipid Res 31:645–652
Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL (1988) Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37:550–557
Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Orekhov AN (1989) Lipoprotein aggregation as an essential condition of intracellular lipid caused by modified low density lipoproteins. Biochem Biophys Res Commun 16:489–494
Bancells C, Benítez S, Jauhiainen M, Ordóñez-Llanos J, Kovanen PT, Villegas S, Sánchez-Quesada JL, Oörni K (2009) High binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation level. J Lipid Res 50:446–455
Talbot RM, del Rio JD, Weinberg PD (2003) Effect of fluid mechanical stresses and plasma constituents on aggregation of LDL. J Lipid Res 44:837–845
Brunelli R, Balogh G, Costa G, De Spirito M, Greco G, Mei G, Nicolai E, Vigh L, Ursini F, Parasassi T (2010) Estradiol binding prevents ApoB-100 misfolding in electronegative LDL(−). Biochemistry 49:7297–7302
Tertov VV, Kaplun VV, Sobenin IA, Orekhov AA (1998) Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis 138:183–195
Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, Solakivi T, Nikkari T, Smirnov VN, Orekhov AN (1992) Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab Invest 67:665–675
Parasassi T, De Spirito M, Mei G, Brunelli R, Greco G, Lenzi L, Maulucci G, Nicolai E, Papi M, Arcovito G, Tosatto SC, Ursini F (2008) Low density lipoprotein misfolding and amyloidogenesis. FASEB J 22:2350–2356
Bancells C, Villegas S, Blanco FJ, Benítez S, Gállego I, Beloki L, Pérez-Cuellar M, Ordóñez-Llanos J, Sánchez-Quesada JL (2010) Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion. J Biol Chem 285:32425–32435
Bancells C, Benítez S, Ordóñez-Llanos J, Öörni K, Kovanen PT, Milne RW, Sánchez-Quesada JL (2011) Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans. J Biol Chem 286:1125–1133
Greco G, Balogh G, Brunelli R, Costa G, De Spirito M, Lenzi L, Mei G, Ursini F, Parasassi T (2009) Generation in human plasma of misfolded, aggregation-prone electronegative low density lipoprotein. Biophys J 97:628–635
Llorente-Cortés V, Badimon L (2005) LDL receptor-related protein and the vascular wall: implications for atherothrombosis. Arterioscler Thromb Vasc Biol 25:497–504
Llorente-Cortés V, Otero-Viñas M, Camino-López S, Costales P, Badimon L (2006) Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26:117–123
Oörni K, Pentikäinen MO, Ala-Korpela M, Kovanen PT (2000) Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J Lipid Res 41:1703–1714
Plihtari R, Kovanen PT, Öörni K (2011) Acidity increases the uptake of native LDL by human monocyte-derived macrophages. Atherosclerosis 217:401–406
Lähdesmäki K, Öörni K, Alanne-Kinnunen M, Jauhiainen M, Hurt-Camejo E, Kovanen PT (2012) Acidity and lipolysis by group V secreted phospholipase A(2) strongly increase the binding of apoB-100-containing lipoproteins to human aortic proteoglycans. Biochim Biophys Acta 1821:257–267
Vinogradov SV, Batrakova EV, Li S, Kabanov AV (2004) Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides. J Drug Target 12:517–526
Batrakova EV, Li S, Alakhov VY, Miller DW, Kabanov AV (2003) Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. Farmacol Exp Ther 304:845–854
Alakhova DY, Rapoport NY, Batrakova EV, Timoshin AA, Li S, Nicholls D, Alakhov VY, Kabanov AV (2010) Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J Controlled Release 142:89–100
Batrakova EV, Li S, Li Y, Alakhov VY, Kabanov AV (2004) Effect of pluronic P85 on ATPase activity of drug efflux transporters. Pharm Res 21:2226–2233
Batrakova EV, Li S, Li Y, Alakhov VY, Elmquist WF, Kabanov AV (2004) Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Controlled Release 100:389–397
Johnston TP, Baker JC, Hall D, Jamal AS, Emeson EE, Palmer WK (1999) Potential downregulation of HMG-CoA reductase following chronic administration of P-407 to C57BL/6 mice. J Cardiovasc Pharmacol 34:831–842
Acknowledgments
This study was supported by the Russian Ministry of Education and Science.
Conflict of interest
No conflict of interest is declared by the authors.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Melnichenko, A.A., Aksenov, D.V., Myasoedova, V.A. et al. Pluronic Block Copolymers Inhibit Low Density Lipoprotein Self-Association. Lipids 47, 995–1000 (2012). https://doi.org/10.1007/s11745-012-3699-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-012-3699-5